A-FABP was identified to be a key mediator in these pathophysiological pathways involved in the development of hypertension, including being associated with endothelial dysfunction through mediating endothelial nitric oxide pathways [100] as well as activation of the sympathetic nervous system [101]. Here, FABP4 is linked to Hypertension.